Clinical Features of Moyamoya Disease: An Overview

2010 ◽  
pp. 107-109 ◽  
Author(s):  
Yong-Seung Hwang
2010 ◽  
Vol 50 (5) ◽  
pp. 378-385 ◽  
Author(s):  
Kentaro HAYASHI ◽  
Kazuhiko SUYAMA ◽  
Izumi NAGATA

Stroke ◽  
1998 ◽  
Vol 29 (7) ◽  
pp. 1347-1351 ◽  
Author(s):  
David Chiu ◽  
Peter Shedden ◽  
Patti Bratina ◽  
James C. Grotta

2013 ◽  
Vol 12 (2) ◽  
pp. 175-180 ◽  
Author(s):  
Maki Mukawa ◽  
Tadashi Nariai ◽  
Yoshiharu Matsushima ◽  
Kikuo Ohno

Object The authors compared the clinical features between familial and sporadic cases of moyamoya disease (MMD) by retrospectively analyzing data on patients with MMD registered in the database of Tokyo Medical and Dental University over a period of 28 years. Methods In total, 383 patients with hospital records at Tokyo Medical and Dental University from 1980 to 2007 were registered into the database. The data on all of these patients were retrospectively reviewed to clarify the occurrence of familial cases. Clinical features of child or adolescent patients (< 20 years of age) with MMD were compared between familial and sporadic cases in a subgroup of patients who were registered after 1995, initially diagnosed using MR angiography, and assessed using an intelligence scale. Results Familial occurrence was observed in 59 patients (15.4%) in 40 pedigrees. The clinical features of juvenile patients were analyzed in 124 patients, 22 (17.7%) of whom had familial histories. In comparison with the sporadic cases, patients with familial histories were significantly younger at onset (4.7 vs 6.6 years old), had significantly more cortical infarction (59.1% vs 25.5%), and had significantly more stenoocclusive lesions in the posterior cerebral artery (45.4% vs 24.5%). The rate of patients with intellectual disturbance (intelligence quotient < 75) was significantly larger in the familial cases (47.4%) than in the sporadic cases (17.8%). Conclusions This survey of the clinical features of familial MMD suggests that patients with familial MMD had a more serious clinical course in childhood than the sporadic MMD cases.


2020 ◽  
Vol 80 ◽  
pp. 274-279
Author(s):  
Peicong Ge ◽  
Xun Ye ◽  
Qian Zhang ◽  
Xingju Liu ◽  
Xiaofeng Deng ◽  
...  

2016 ◽  
Vol 96 ◽  
pp. 474-482 ◽  
Author(s):  
Qian Zhang ◽  
Rong Wang ◽  
Yaping Liu ◽  
Yan Zhang ◽  
Shuo Wang ◽  
...  

2015 ◽  
Vol 32 (3) ◽  
pp. 569-573 ◽  
Author(s):  
Ayşe Kaçar Bayram ◽  
Ebru Yilmaz ◽  
Huseyin Per ◽  
Masaki Ito ◽  
Haruto Uchino ◽  
...  

2015 ◽  
Vol 122 (2) ◽  
pp. 392-399 ◽  
Author(s):  
Xing-ju Liu ◽  
Dong Zhang ◽  
Shuo Wang ◽  
Yuan-li Zhao ◽  
Mario Teo ◽  
...  

OBJECT The aim of this study was to describe the baseline clinical features and long-term outcomes of patients with moyamoya disease (MMD) based on a 25-year period at a single center in China. METHODS  Data obtained in 528 consecutive patients with MMD treated at the authors' hospital from 1984 to 2010 were reviewed retrospectively. Events of transient ischemic attack, new infarction, and hemorrhage were included. The Kaplan-Meier risk of stroke was calculated. RESULTS  The mean (± SD) patient age was 26 ± 13 years (range 2–67 years), and the female/male ratio was 0.9:1. There were 332 cases of ischemia and 196 hemorrhages. Adults had a higher rate of bleeding than children (50.7% vs 14.0%, respectively; p < 0.001). One hundred twenty-two patients were treated conservatively, and 406 patients underwent revascularization procedures. Of 528 patients, 331 (62.7%) had at least 1 year of follow-up (median 39.5 months) and data from these patients were analyzed. Rebleeding and mortality rates in patients with hemorrhagic MMD (n = 104) were higher than in those with ischemic MMD (n = 227) (26.9% vs 2.2% [p < 0.001] and 4.8% vs 0.4% [p < 0.05], respectively). Twenty-five of 60 (41.7%) conservatively treated patients and 8 of 271 (2.9%) surgically treated patients experienced rebleeding events, a difference that was significant in the Kaplan-Meier curve of rebleeding (p < 0.01). An improvement in perfusion was found in 164 of 224 (73.2%) surgically treated patients 1 month after discharge. However, there was no significant difference in the rate of ischemic events in the surgical and conservative groups (18.8% and 28.3%, respectively; p = 0.09). Among the 104 hemorrhagic cases, rebleeding attacks were observed in 25 patients in the nonsurgical group (n = 60) and 3 patients in the surgical group (n = 44) (41.7% and 6.8%, respectively; OR 9.7 [95% CI 2.7–35.0]; p < 0.01). CONCLUSIONS  There was no difference in the sex distribution of Chinese patients with MMD. Patients with hemorrhagic MMD had a much higher rate of rebleeding and poorer prognosis than those with the ischemic type. Surgical revascularization procedures can improve cerebral perfusion and have a positive impact in preventing rebleeding in patients with hemorrhagic MMD.


2019 ◽  
Vol 186 ◽  
pp. 105505
Author(s):  
Junlin Lu ◽  
Yahui Zhao ◽  
Li Ma ◽  
Yu Chen ◽  
Mingtao Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document